RMD (ResMed Inc) Return on Gross Profit

Corporate emblem and logo of ResMed Inc (RMD)

Under the leadership of Mick Farrell, ResMed Inc. (RMD) focuses on digital health and supply chain optimization. The gross margin trajectory demonstrates the business's actual operational yield, while 60.50 reflects the metric's latest value. The brand's global authority in sleep apnea treatment ensures patient trust, while the AirView cloud system creates significant barriers to entry for competitors, strengthening the company's market position.

resmed.com (RMD) Gross Profitability: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for ResMed Inc (RMD)

- current quotes and average value forecast:
- business market valuation indicators:
Basic company analysis:RMD (ResMed Corp)
Manufactured products of ResMed

ResMed Inc. (RMD) generates its primary revenue through the sale of apnea therapy equipment and high-margin SaaS services. The gross margin trend reflects the efficiency of managing direct production costs for these products. This metric is calculated as the remaining revenue after deducting the cost of goods sold, measuring the company's ability to convert sales into operating capital. The stability of this metric confirms the competitive advantage and high profitability of the issuer's business model.

Key competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|OmniPod (PODD) - Return on Sales by Gross Profit|Gross Margin ZBH|Gross Margin coopercos.com (COO)|Gross Margin ALGN (aligntech.com)|Gross Margin Globus Medical Inc GMED|TMDX - Gross Profitability|ATEC: Gross Profitability|AORT (Artivion, Inc.) - Return on Gross Profit|Enovis Corporation - Gross Profit Rate|IART (Integra LifeSciences Inc.) - Gross Margin|Gross Profit Margin Establishment Labs Corp ESTA|Gross Profitability Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO